Markets
KRO

DuPont Launches EverpreX Soybean Herbicide to Protect Crops

An image of a stock chart with money, a calculator and a pen lying on it.
Credit: Shutterstock photo

DuPont 's DD Crop Protection business has introduced EverpreX herbicide that offers extended residual control of ALS-, PPO- and/or glyphosate resistant weeds, including waterhemp, Palmer amaranth and other pigweed species.

EverpreX is a valuable solution for weed resistance as it helps safeguard yield potential by minimizing competition for nutrients, moisture and sunlight.

EverpreX provides excellent weed resistance when tank-mixed with glyphosate herbicides, such as DuPont Abundit Edge. It provides a residual control of Palmer amaranth, waterhemp, lambsquarters, nightshade, foxtails and other small-seeded grasses and broadleaf weeds when tank-mixed with other pre- or postemergence herbicides.

EverpreX is compatible and can be easily mixed with many other soybean herbicides. Also, it contains S-metolachlor for residual control via inhibition of shoot- and root-tissue growth soon after weed germination.

The herbicide has the flexibility to be applied 45 days prior to planting and up to 90 days before harvest. It can be used as an early preplant, preplant incorporated, pre-emergence or postemergence herbicide that provides recropping adaptability when rotating from soybeans to other crops.

DuPont has outperformed the industry over a year. The company's shares have rallied 18.2% compared with the industry's 17.9% gain during this period.

DuPont kept its positive earnings surprise streak alive with a solid beat in second-quarter 2017. The company recorded adjusted earnings per share of $1.38 in the reported quarter, up 11% from $1.24 a year ago. Results topped the Zacks Consensus Estimate of $1.29. DuPont logged net sales of $7,424 million, up roughly 5% year over year on higher volumes. The figure surpassed the Zacks Consensus Estimate of $$7,260 million.

DuPont is well-positioned to gain from cost-cutting and productivity improvement measures plus product launches. The company has numerous new products in pipeline, expected to create value for customers.

E.I. du Pont de Nemours and Company Price and Consensus

E.I. du Pont de Nemours and Company Price and Consensus | E.I. du Pont de Nemours and Company Quote

Zacks Rank & Stocks to Consider

DuPont currently carries a Zacks Rank #3 (Hold).

Some better-ranked companies in the chemical space include are The Chemours Company CC , Kronos Worldwide KRO and Akzo Nobel N.V. AKZOY . All three stocks sport a Zacks Rank #1 (Strong Buy). You can see the complete list of today's Zacks #1 Rank stocks here .

Chemours has an expected long-term earnings growth of 15.5%.

Kronos Worldwide has an expected long-term earnings growth of 5%.

Akzo Nobel has an expected long-term earnings growth of 11.1%.

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market's record highs, but picking the best ones to buy can be tough. There's a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now - before the next wave of innovations really takes off.

See Stocks Now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

E.I. du Pont de Nemours and Company (DD): Free Stock Analysis Report

Kronos Worldwide Inc (KRO): Free Stock Analysis Report

Chemours Company (The) (CC): Free Stock Analysis Report

Akzo Nobel NV (AKZOY): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

KRO AKZOY CC

Other Topics

Stocks

Latest Markets Videos

Zacks

Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

Learn More